Based on ratings from 0 stock analysts, the PepGen Inc. stock price is expected to increase by 118.51% in 12 months. This is calculated by using the average 12-month stock price forecast for PepGen Inc.. The lowest target is $10 and the highest is $26. Please note analyst price targets are not guaranteed and could be missed completely.
PepGen Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that PepGen Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of PEPG.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Andrew Fein HC Wainwright & Co. | Buy | $26 | Reiterates | Aug 1, 2024 |
Laura Chico Wedbush | Outperform | $20 | Reiterates | Jul 31, 2024 |
Laura Chico Wedbush | Outperform | $20 | Reiterates | May 15, 2024 |
Andrew Fein HC Wainwright & Co. | Buy | $26 | Reiterates | May 15, 2024 |
Laura Chico Wedbush | Outperform | $20 | Maintains | Mar 7, 2024 |
Laura Chico Wedbush | Outperform | $21 | Reiterates | Jan 30, 2024 |
Andrew Fein HC Wainwright & Co. | Buy | $26 | Reiterates | Sep 7, 2023 |
HC Wainwright & Co. | Buy | Reiterates | Aug 9, 2023 | |
Paul Matteis Stifel | Buy | $24 | Reiterates | Jun 14, 2023 |
Laura Chico Wedbush | Outperform | $22 | Reiterates | Jun 14, 2023 |
Laura Chico Wedbush | Outperform | $22 | Reiterates | May 31, 2023 |
Andrew Fein HC Wainwright & Co. | Buy | $26 | Reiterates | May 12, 2023 |
Andrew Fein HC Wainwright & Co. | Buy | $26 | Reiterates | Apr 3, 2023 |
Andrew Fein HC Wainwright & Co. | Buy | $26 | Reiterates | Mar 24, 2023 |
Laura Chico Wedbush | Outperform | $22 | Maintains | Mar 24, 2023 |
Andrew Fein HC Wainwright & Co. | Buy | $26 | Initiates | Dec 21, 2022 |
Joseph Schwartz SVB Leerink | Outperform | $33 | Maintains | Nov 10, 2022 |
Tazeen Ahmad B of A Securities | Buy | $16 | Initiates | May 31, 2022 |
Paul Matteis Stifel | Buy | $24 | Initiates | May 31, 2022 |
Joseph Schwartz SVB Leerink | Outperform | $40 | Initiates | May 31, 2022 |
When did it IPO
2022
Staff Count
72
Country
United States
Sector/Industry
Healthcare/Biotechnology
CEO
Dr. James G. McArthur Ph.D.
Market Cap
$301.5M
In 2023, PEPG generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that PEPG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.